CARRATU', Pierluigi
 Distribuzione geografica
Continente #
NA - Nord America 11.646
AS - Asia 3.929
EU - Europa 3.235
SA - Sud America 1.065
Continente sconosciuto - Info sul continente non disponibili 351
AF - Africa 150
OC - Oceania 11
Totale 20.387
Nazione #
US - Stati Uniti d'America 11.396
SG - Singapore 1.657
IT - Italia 969
CN - Cina 932
BR - Brasile 853
HK - Hong Kong 494
SE - Svezia 466
DE - Germania 363
RU - Federazione Russa 330
UA - Ucraina 251
FI - Finlandia 240
FR - Francia 215
VN - Vietnam 212
GB - Regno Unito 198
IN - India 129
CA - Canada 100
BD - Bangladesh 82
AR - Argentina 70
IQ - Iraq 61
ID - Indonesia 58
MX - Messico 46
TR - Turchia 45
ZA - Sudafrica 37
EC - Ecuador 36
CO - Colombia 35
JP - Giappone 35
IE - Irlanda 31
UZ - Uzbekistan 31
VE - Venezuela 31
SA - Arabia Saudita 29
ES - Italia 27
PK - Pakistan 25
BE - Belgio 24
CI - Costa d'Avorio 23
PL - Polonia 22
MA - Marocco 20
CW - ???statistics.table.value.countryCode.CW??? 19
CZ - Repubblica Ceca 19
CR - Costa Rica 18
NL - Olanda 18
LT - Lituania 17
PH - Filippine 17
MY - Malesia 16
AT - Austria 15
HN - Honduras 15
NI - Nicaragua 15
EG - Egitto 14
TN - Tunisia 14
AE - Emirati Arabi Uniti 13
JM - Giamaica 12
KE - Kenya 12
PE - Perù 12
GT - Guatemala 11
NP - Nepal 11
PY - Paraguay 11
SV - El Salvador 10
DZ - Algeria 9
JO - Giordania 9
IL - Israele 8
TT - Trinidad e Tobago 8
AU - Australia 7
KZ - Kazakistan 7
LB - Libano 7
AZ - Azerbaigian 6
CH - Svizzera 6
CL - Cile 6
IR - Iran 6
BH - Bahrain 5
BO - Bolivia 5
ET - Etiopia 5
OM - Oman 5
PA - Panama 5
UY - Uruguay 5
NG - Nigeria 4
PS - Palestinian Territory 4
SC - Seychelles 4
TW - Taiwan 4
AL - Albania 3
EU - Europa 3
GE - Georgia 3
KG - Kirghizistan 3
QA - Qatar 3
RS - Serbia 3
SY - Repubblica araba siriana 3
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GP - Guadalupe 2
GR - Grecia 2
KR - Corea 2
ML - Mali 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PT - Portogallo 2
RO - Romania 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
Totale 20.039
Città #
Ashburn 1.618
Fairfield 1.013
Woodbridge 863
Singapore 855
Chandler 831
San Jose 734
Jacksonville 571
Houston 554
Hong Kong 494
Seattle 430
Milan 393
Nyköping 362
Ann Arbor 353
Cambridge 348
Wilmington 314
Beijing 244
Council Bluffs 230
Roxbury 175
Lawrence 174
Nanjing 172
Lauterbourg 156
Dearborn 142
New York 126
Rome 120
São Paulo 120
Los Angeles 118
Des Moines 115
Boardman 98
Dallas 97
Helsinki 94
Santa Clara 89
Brooklyn 69
Bari 65
Columbus 61
Ho Chi Minh City 60
San Diego 52
Buffalo 49
Princeton 48
Hebei 44
Hanoi 43
Munich 42
London 40
Shenyang 39
Inglewood 36
Jiaxing 35
Toronto 35
Turin 35
Chicago 33
Jakarta 33
Tokyo 33
Atlanta 32
Dublin 31
Figino 29
Rio de Janeiro 29
Dong Ket 28
Nanchang 28
Orem 27
Brussels 24
Abidjan 23
Hefei 23
Changsha 22
Phoenix 22
Tashkent 22
Baghdad 21
Johannesburg 21
Taranto 21
Turi 20
Belo Horizonte 19
Frankfurt am Main 19
Moscow 19
Paris 18
Warsaw 18
Guangzhou 17
Pune 17
Curitiba 16
Denver 16
Kunming 16
Mexico City 16
Montreal 16
Tianjin 16
Willemstad 16
Managua 15
Olomouc 15
Dhaka 14
Jinan 14
Nuremberg 14
Redwood City 14
Stockholm 14
Boston 13
Brasília 13
Guayaquil 13
Istanbul 13
Mottola 13
New Delhi 13
Bologna 12
Chennai 12
Las Vegas 12
Salvador 12
San Francisco 12
Vilnius 12
Totale 13.767
Nome #
An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls 296
Voluntary lung function screening to reveal new COPD cases in southern Italy 268
Correction of intermittent hypoxia reduces inflammation in obese subjects with obstructive sleep apnea 233
Analysis of aortic remodeling and stiffness in patients with obstructive sleep apnea syndrome: Preliminary results 210
An Electronic Nose Discriminates between the Exhaled Breath of Patients with Pleural Malignant Mesothelioma and Healthy Controls, 197
Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis 193
Clinical and Functional Lung Parameters Associated With Frequent Exacerbator Phenotype in Subjects With Severe COPD 191
Acute parenchymal lung involvement in a 68-year-old woman with systemic lupus erythematosus, anemia, and thrombocytopenia 186
An electronic nose in the discrimination of obese patients with and without obstructive sleep apnoea 185
Assessment of Induced Sputum Cellularity in COPD Patients Belonging to Two Different Classes of Air Pollution Exposure 183
Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea 177
Enviromental Asbestos Exposure as a Risk Factor for Small Airways Obstruction 172
And the patient said: Let me be able to breathe and dream 172
Correlations between severity of obstructive sleep apnoea and systolic pulmonary artery pressure: preliminary results 168
Influence of age and gender on the profile of exhaled volatile organic compounds analyzed by an electronic nose 167
Evaluation of endothelial function and cardiovascular risk in non-obese patients with slight degree of obstructive sleep apnea syndrome 165
A case of cryptogenic organizing pneumonia occurring in Crohn's disease 163
Obstructive Sleep Apnea, Hypertension, and Their Additive Effects on Atherosclerosis 161
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 160
Ovarian cycle may influence the exhaled volatile organic compounds profile analyzed by an electronic nose 160
Enviromental asbestos exposure as a risk factor for small airways obstruction 151
Does Nocturnal Hypoventilation Have a Protective Effect on Cardiovascular Comorbidity in Obesity Hypoventilation Syndrome? 151
Nocturnal Hypoventilation May Have a Protective Effect on Ischemic Heart Disease in Patients with Obesity Hypoventilation Syndrome 151
A Portable Device as Sleep-Screening Tool in the Identification of Obstructive Sleep Apnea in Chronic Heart Failure: Which Value Should We Consider as Cutoff? 150
The role of education in the self-compilation of Epworth sleepiness scale questionnaire in patients with suspected obstructive sleep apnea 150
Comment on: Hostettler K, et al. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial 149
The importance of maintaining the same order of performance of lung function and SNIP tests in patients with amyotrophic lateral sclerosis 149
Atrial flutter regression in HIV-associated pulmonary arterial hypertension after treatment with bosentan 147
HIGH DOSES OF M-TOR INHIBITORS MAY INDUCE PULMONARY PRO-FIBROTIC EFFECTS IN RENAL TRANSPLANT RECIPIENTS: RESULT OF A TRANSLATIONAL COMPARATIVE RESEARCH APPROACH BETWEEN PROGRAF VERSUS EVEROLIMUS 145
A new approach for the assessment of sleepiness and predictivity of obstructive sleep apnea in drivers: A pilot study 145
An electronic nose may sniff out amyotrophic lateral sclerosis 143
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD 143
Exhaled breath profiling in patients with COPD and OSA overlap syndrome: A pilot study 143
Alterazioni del metabolismo dell'endotelina-1 in pazienti con tromboembolia polmonare 140
In vitro identification of new transcriptomic and miRNomic profiles associated with pulmonary fibrosis induced by high doses everolimus: Looking for new pathogenetic markers and therapeutic targets 140
Endogenous Endothelin-1 production/excretion in patients with COPD 137
Correlation between pulse transit time and microvascular impairment in OSAS patients 137
Association between low sniff nasal-inspiratory pressure (SNIP) and sleep disordered breathing in amyotrophic lateral sclerosis: Preliminary results. 136
An electronic nose distinguishes the exhaled breath of obese patients with obstructive sleep apnoea (OSA) from subjects with a similar body mass index and without OSA 136
Using PaCO2 values to grade obesity-hypoventilation syndrome severity: a retrospective study 136
A60 antigen, as a new tuberculin 135
Lack of association between OSAS and Hypothyroidism 134
Dose-related effect of sodium cromoglycate in reducing methacoline-induced bronchocostriction 133
Endogenous heme oxygenase prevents impairment of cerebral vascular functions caused by seizures 133
Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma 133
An electronic nose discriminates exhaled breath of patients with untreated Pulmonary Sarcoidosis from controls 131
Increased IL-6 and IL-4 in exhaled breath condensate of patients with nasal polyposis 130
Electronic Nose Technology in Respiratory Diseases 130
OSA, BPCO e sindrome infiammatoria cronica sistemica 128
TITRATION EFFECTIVENESS OF TWO AUTOCPAP DEVICES DRIVEN BY DIFFERENT ALGORITHMS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA 128
24-hours Endothelin-1 urinary excretion in patients with Interstitial Lung Disease 128
Epileptic seizures cause extended postictal cerebral vascular dysfunction that is prevented by HO-1 overexpression 127
Bilateral diaphragmatic paralysis after kidney surgery 127
Slepp apnea exacerbates the microvascular impairment in mild hypertensives 126
Severe obstructive sleep apnoea exacerbates the microvascular impairment in very mild hypertensives 124
Smoking Habit in Severe Obese after bariatric procedures. 124
Incidence of deep venous thrombosis in patients with both pulmonary embolism and copd 124
Influence of subclinical hypothyroidism and T4 treatment on the prevalence and severity of obstructive sleep apnoea syndrome (OSAS) 123
Role of plasmatic leptin in response to hypercapnia in obese patients with or without osas 123
The Prognostic Role of Obstructive Sleep Apnea at the Onset of Amyotrophic Lateral Sclerosis 123
Increased 24-hour endothelin-1 urinary excretion in patients with chronic obstructive pulmonary disease. 122
Sniff Nasal Pressure Is a Sensitive Marker of Poor Outcome in Amyotrophic Lateral Sclerosis 122
Home Unattended Portable Monitoring and AutoCPAP Titration In Patients With High Risk for Moderate to Severe OSA. 120
Abnormalities of Endothelin-1 metabolism in Pulmonary Embolism 118
Hyperventilation In Patients With Pulmonary Arterial Hypertension Is Related To Increased Chemosensitivity 117
Is obstructive sleep apnoea a comorbidity of COPD and is it involved in chronic systemic inflammatory syndrome? 117
Clinical variability of respiratory pulmonary hypertension: implications for diagnosis and management 117
Is there a correlation between OSAS duration/severity and carotid intima-media thickness? 117
Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease 117
An electronic nose in the diagnostic assessment of asthma in pediatric patients 116
Predictive equations for CPAP titration in OSAS patients 116
Evaluation of a transcutaneous carbon dioxide monitor in severe obesity 115
Effect of zafirlukast on methacholine and ultrasonically nebulized distilled water challenge in patients with mild asthma. 115
Low exhaled nitric oxide in severe uncomplicated obesity 114
EVEROLIMUS-INDUCED EPITHELIAL TO MESENCHYMAL TRANSITION IN BRONCHIAL AND PULMONARY CELLS: WHEN THE DOSAGE DOES MATTER IN TRANSPLANTATION 114
Efficacy of positional therapy in treatment of patients with obstructive sleep apnea: a pilot study 113
Interleukin-8 and soluble intercellular adhesion molecule 1 during acute respiratory distress syndrome and in response to prolonged methylprednisolone treatment 112
Noninvasive ventilation (NIV) in the management of chronic heart failure (CHF) 111
CD8+ T-cell alveolitis in familial pulmonary alveolar microlithiasis 111
Exhaled Volatile Organic Compounds analysis by e-nose can detect Idiopathic Pulmonary Fibrosis 111
Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency 110
Failure of noninvasive ventilation during hypercapnic exacerbation of chronic obstructive pulmonary disease: the role of chronic kidney diseases 110
Relationship between skin tests and lung function in school children exposed to different levels of air pollution 109
Heme oxygenase inhibition reduces neuronal activation evoked by bicuculline in newborn pigs. 109
La presenza di apnea notturna peggiora il danno microcircolatorio sin dalle prime fasi dell'ipertensione arteriosa 108
End points for pulmonary arterial hypertension: a way backward. 107
Excessive daytime sleepiness in women without OSA 107
Reversibility of the endothelial dysfunction after CPAP therapy in OSAS patients 107
Zafirlukast single oral dose pre-treatment prevents FEV1 drop after bronchial challenge in mild asthma 106
Aumento dell'escrezione urinaria di Endotelina-1 in pazienti affetti da BPCO 105
Influence of obstructive sleep apnea on endothelial function in obese patients. 104
Risposta umorale e cellulare all’antigene micobatterico A60 nella diagnosi di TBC. 104
Could neutrophilic airway inflammation in obese people be more due to obstructive sleep apnoea syndrome than to asthma? 104
Is there a correlation between OSAS duration/severity and carotid intima-media thickness? 104
Exhaled breath condensate as matrix for toluene detection: a preliminary study 104
Role of Endothelin in Acute and Chronic Pulmonary Disease 103
Home mechanical ventilation (HMV) decreases mortality in patients affected by amyotrophic lateral sclerosis (ALS 101
Recurrent Pulmonary Embolism Echinococcosis Secondary to Hepatic Surgery for Hydatid Cysts 101
HPV16 E7-dependent transformation activates NHE1 through a PKA-RhoA-induced inhibition of p38alpha 101
Correlation between sniff nasal inspiratory pressure (snip) and amyotrophic lateral sclerosis functional rating scale (alsfrs) in als patients 99
Totale 13.668
Categoria #
all - tutte 83.364
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.364


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022965 0 0 0 89 49 76 40 67 75 56 170 343
2022/20231.952 266 185 120 204 259 300 17 197 337 8 26 33
2023/2024610 51 124 38 43 67 136 37 31 4 19 4 56
2024/20252.629 41 33 246 75 48 212 177 245 132 123 410 887
2025/20265.656 812 257 268 553 626 295 634 155 594 535 194 733
2026/20272.092 141 298 524 1.129 0 0 0 0 0 0 0 0
Totale 20.387